These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20957307)

  • 1. Botulinum toxin a for idiopathic detrusor overactivity.
    Lie KY; Wong MY; Ng LG
    Ann Acad Med Singap; 2010 Sep; 39(9):714-5. PubMed ID: 20957307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of botulinum toxin-A in refractory idiopathic overactive bladder patients without detrusor overactivity.
    Kanagarajah P; Ayyathurai R; Caruso DJ; Gomez C; Gousse AE
    Int Urol Nephrol; 2012 Feb; 44(1):91-7. PubMed ID: 21643644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial.
    Sahai A; Dowson C; Khan MS; Dasgupta P
    BJU Int; 2009 Jun; 103(11):1509-15. PubMed ID: 19389019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results.
    Schurch B; Stöhrer M; Kramer G; Schmid DM; Gaul G; Hauri D
    J Urol; 2000 Sep; 164(3 Pt 1):692-7. PubMed ID: 10953127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of urodynamic and detrusor contractility variables in patients with overactive bladder syndrome treated with botulinum toxin-A: is incomplete bladder emptying predictable?
    Sahai A; Sangster P; Kalsi V; Khan MS; Fowler CJ; Dasgupta P
    BJU Int; 2009 Mar; 103(5):630-4. PubMed ID: 18990156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urodynamic assessment of children treated with botulinum toxin A injections for urge incontinence: a pilot study.
    Lahdes-Vasama TT; Anttila A; Wahl E; Taskinen S
    Scand J Urol Nephrol; 2011 Dec; 45(6):397-400. PubMed ID: 21740110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Objective and subjective improvement in children with idiopathic detrusor overactivity after intravesical botulinum toxin injection: A preliminary report.
    Al Edwan GM; Mansi HH; Atta ONM; Shaath MM; Al Adwan R; Mahafza W; Afram KM; Ababneh O; Al Adwan D; Muheilan MM
    J Pediatr Surg; 2019 Mar; 54(3):595-599. PubMed ID: 29887168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined detrusor-trigone BTX-A injections for urinary incontinence secondary to neurogenic detrusor overactivity.
    Hui C; Keji X; Chonghe J; Ping T; Rubiao O; Jianweng Z; Xiangrong D; Liling Z; Maping H; Qingqing L; Qiuling L; Jiebing H; Tanghai H
    Spinal Cord; 2016 Jan; 54(1):46-50. PubMed ID: 26261074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin type A for refractory neurogenic detrusor overactivity in spinal cord injured patients in Singapore.
    Tow AM; Toh KL; Chan SP; Consigliere D
    Ann Acad Med Singap; 2007 Jan; 36(1):11-7. PubMed ID: 17285181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switch to Abobotulinum toxin A may be useful in the treatment of neurogenic detrusor overactivity when intradetrusor injections of Onabotulinum toxin A failed.
    Bottet F; Peyronnet B; Boissier R; Reiss B; Previnaire JG; Manunta A; Kerdraon J; Ruffion A; Lenormand L; Perrouin Verbe B; Gaillet S; Gamé X; Karsenty G;
    Neurourol Urodyn; 2018 Jan; 37(1):291-297. PubMed ID: 28431196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the impact on health-related quality of life of repeated detrusor injections of botulinum toxin in patients with idiopathic or neurogenic detrusor overactivity.
    Gamé X; Khan S; Panicker JN; Kalsi V; Dalton C; Elneil S; Hamid R; Dasgupta P; Fowler CJ
    BJU Int; 2011 Jun; 107(11):1786-92. PubMed ID: 21040367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
    Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
    Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.
    Giannantoni A; Rossi A; Mearini E; Del Zingaro M; Porena M; Berardelli A
    J Urol; 2009 Oct; 182(4):1453-7. PubMed ID: 19683298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin-A for idiopathic overactivity of the vesical detrusor: a 2-year follow-up.
    Kuschel S; Werner M; Schmid DM; Faust E; Schuessler B
    Int Urogynecol J Pelvic Floor Dysfunct; 2008 Jul; 19(7):905-9. PubMed ID: 18204796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intradetrusor injection of botulinum-A toxin in patients with idiopathic and neurogenic detrusor overactivity: urodynamic outcome and patient satisfaction.
    Ghalayini IF; Al-Ghazo MA
    Neurourol Urodyn; 2007; 26(4):531-536. PubMed ID: 17330289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated injections of botulinum toxin-A for idiopathic detrusor overactivity.
    Sahai A; Dowson C; Khan MS; Dasgupta P;
    Urology; 2010 Mar; 75(3):552-8. PubMed ID: 20035984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the exact working mechanism of botulinum toxin A and sacral nerve stimulation in the treatment of overactive bladder/detrusor overactivity? ICI-RS 2017.
    Malde S; Fry C; Schurch B; Marcelissen T; Averbeck M; Digesu A; Sahai A
    Neurourol Urodyn; 2018 Jun; 37(S4):S108-S116. PubMed ID: 30133790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra.
    Smith CP; Nishiguchi J; O'Leary M; Yoshimura N; Chancellor MB
    Urology; 2005 Jan; 65(1):37-41. PubMed ID: 15667859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intravesical botulinum neurotoxin-A injection on detrusor hyperreflexia in spinal cord injured patients.
    Ge XT; Li YF; Wang Q; Zhao JN
    Drug Res (Stuttg); 2015 Jun; 65(6):327-31. PubMed ID: 25350080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum-A Toxin's efficacy in the treatment of idiopathic overactive bladder.
    Moga MA; Banciu S; Dimienescu O; Bigiu NF; Scarneciu I
    J Pak Med Assoc; 2015 Jan; 65(1):76-80. PubMed ID: 25831681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.